250 related articles for article (PubMed ID: 33265920)
21. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Afach S; Doney L; Dressler C; Hua C; Mazaud C; Phan C; Hughes C; Riddle D; Naldi L; Garcia-Doval I; Le Cleach L
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD011535. PubMed ID: 31917873
[TBL] [Abstract][Full Text] [Related]
22. Natural history of neonatal herpes simplex virus infections in the acyclovir era.
Kimberlin DW; Lin CY; Jacobs RF; Powell DA; Frenkel LM; Gruber WC; Rathore M; Bradley JS; Diaz PS; Kumar M; Arvin AM; Gutierrez K; Shelton M; Weiner LB; Sleasman JW; de Sierra TM; Soong SJ; Kiell J; Lakeman FD; Whitley RJ;
Pediatrics; 2001 Aug; 108(2):223-9. PubMed ID: 11483781
[TBL] [Abstract][Full Text] [Related]
23. COMPARATIVE EFFICACY OF ANTIVIRAL AGENTS FOR PREVENTION AND MANAGEMENT OF HERPES LABIALIS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS.
Koe KH; Veettil SK; Maharajan MK; Syeed MS; Nair AB; Gopinath D
J Evid Based Dent Pract; 2023 Mar; 23(1):101778. PubMed ID: 36914303
[TBL] [Abstract][Full Text] [Related]
24. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
Liesveld JL; Abboud CN; Ifthikharuddin JJ; Lancet JE; Wedow LA; Oliva J; Stamm CG; Nichols D
Biol Blood Marrow Transplant; 2002; 8(12):662-5. PubMed ID: 12523578
[TBL] [Abstract][Full Text] [Related]
25. Antiviral Therapy for Varicella Zoster Virus (VZV) and Herpes Simplex Virus (HSV)-Induced Anterior Uveitis: A Systematic Review and Meta-Analysis.
Testi I; Aggarwal K; Jaiswal N; Dahiya N; Thng ZX; Agarwal A; Ahuja A; Duggal M; Kankaria A; Ling Ho S; Chee SP; Westcott M; Pavesio C; Agrawal R; Gupta V
Front Med (Lausanne); 2021; 8():686427. PubMed ID: 34277661
[No Abstract] [Full Text] [Related]
26. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
[TBL] [Abstract][Full Text] [Related]
27. Interventions for prevention of herpes simplex labialis (cold sores on the lips).
Chi CC; Wang SH; Delamere FM; Wojnarowska F; Peters MC; Kanjirath PP
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD010095. PubMed ID: 26252373
[TBL] [Abstract][Full Text] [Related]
28. Valacyclovir versus acyclovir for the treatment of herpes zoster ophthalmicus in immunocompetent patients.
Schuster AK; Harder BC; Schlichtenbrede FC; Jarczok MN; Tesarz J
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD011503. PubMed ID: 27841441
[TBL] [Abstract][Full Text] [Related]
29. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
[TBL] [Abstract][Full Text] [Related]
30. Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis.
Nicolatou-Galitis O; Athanassiadou P; Kouloulias V; Sotiropoulou-Lontou A; Dardoufas K; Polychronopoulou A; Gonidi M; Kyprianou K; Kolitsi G; Skarleas C; Pissakas G; Papanikolaou IS; Kouvaris J
Support Care Cancer; 2006 Jul; 14(7):753-62. PubMed ID: 16402233
[TBL] [Abstract][Full Text] [Related]
31. Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus disease after allogeneic hematopoietic stem cell transplantation.
Kawamura K; Wada H; Yamasaki R; Ishihara Y; Sakamoto K; Ashizawa M; Sato M; Machishima T; Terasako K; Kimura SI; Kikuchi M; Nakasone H; Yamazaki R; Kanda J; Kako S; Tanihara A; Nishida J; Kanda Y
Transpl Infect Dis; 2013 Oct; 15(5):457-65. PubMed ID: 23895431
[TBL] [Abstract][Full Text] [Related]
32. Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients.
Warkentin DI; Epstein JB; Campbell LM; Yip JG; Cox VC; Ransier A; Barnett MJ; Marra F
Ann Pharmacother; 2002 Oct; 36(10):1525-31. PubMed ID: 12243600
[TBL] [Abstract][Full Text] [Related]
33. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
Beeson WH; Rachel JD
Dermatol Surg; 2002 Apr; 28(4):331-6. PubMed ID: 11966791
[TBL] [Abstract][Full Text] [Related]
34. Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.
Breier A; Buchanan RW; D'Souza D; Nuechterlein K; Marder S; Dunn W; Preskorn S; Macaluso M; Wurfel B; Maguire G; Kakar R; Highum D; Hoffmeyer D; Coskinas E; Litman R; Vohs JL; Radnovich A; Francis MM; Metzler E; Visco A; Mehdiyoun N; Yang Z; Zhang Y; Yolken RH; Dickerson FB
Schizophr Res; 2019 Apr; 206():291-299. PubMed ID: 30478008
[TBL] [Abstract][Full Text] [Related]
35. Association of the Emergence of Acyclovir-Resistant Herpes Simplex Virus Type 1 With Prognosis in Hematopoietic Stem Cell Transplantation Patients.
Kakiuchi S; Tsuji M; Nishimura H; Yoshikawa T; Wang L; Takayama-Ito M; Kinoshita H; Lim CK; Fujii H; Yamada S; Harada S; Oka A; Mizuguchi M; Taniguchi S; Saijo M
J Infect Dis; 2017 Mar; 215(6):865-873. PubMed ID: 28453848
[TBL] [Abstract][Full Text] [Related]
36. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro.
Schuhmacher A; Reichling J; Schnitzler P
Phytomedicine; 2003; 10(6-7):504-10. PubMed ID: 13678235
[TBL] [Abstract][Full Text] [Related]
37. A systematic review of viral infections associated with oral involvement in cancer patients: a spotlight on Herpesviridea.
Elad S; Zadik Y; Hewson I; Hovan A; Correa ME; Logan R; Elting LS; Spijkervet FK; Brennan MT;
Support Care Cancer; 2010 Aug; 18(8):993-1006. PubMed ID: 20544224
[TBL] [Abstract][Full Text] [Related]
38. Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.
Wald A; Timmler B; Magaret A; Warren T; Tyring S; Johnston C; Fife K; Selke S; Huang ML; Stobernack HP; Zimmermann H; Corey L; Birkmann A; Ruebsamen-Schaeff H
JAMA; 2016 Dec; 316(23):2495-2503. PubMed ID: 27997653
[TBL] [Abstract][Full Text] [Related]
39. Antiviral activity of a selective ribonucleotide reductase inhibitor against acyclovir-resistant herpes simplex virus type 1 in vivo.
Duan J; Liuzzi M; Paris W; Lambert M; Lawetz C; Moss N; Jaramillo J; Gauthier J; Déziel R; Cordingley MG
Antimicrob Agents Chemother; 1998 Jul; 42(7):1629-35. PubMed ID: 9660995
[TBL] [Abstract][Full Text] [Related]
40. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
Fife KH; Warren TJ; Justus SE; Heitman CK;
Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
